Sign in
4

Changes in Ownership

Kalaris Therapeutics, Inc. Filed Acc 0001209191-23-012250

Chief Executive Officer sold 5,122 shares at $6.63 ($33,935)

From the SEC's structured data for this filing

Trades in this filing

Brainard Diana · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-02-21 Sale : show line 1 in the form −5,122 $6.63 $33,935 929,572 D
Open-market sales · 5,122 sh · avg $6.63 · $33,935
Loading xslF345X03/doc4.xml…